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Background and Purpose—We addressed whether dynamic cerebral autoregulation (dCA) is affected in middle cerebral
artery (MCA) territory (MCAS) and lacunar ischemic stroke (LS).
Methods—Blood pressure (MAP) and MCA velocity (V) were measured in 10 patients with large MCAS (National
Institutes of Health Stroke score, 172; meanSEM), in 10 with LS (score, 91), and in 10 reference subjects. dCA
was evaluated in time (delay of the MCA Vmean counter-regulation during changes in MAP) and frequency domains
(cross-spectral MCA Vmean-to-MAP phase lead).
Results—In reference subjects, latencies for MAP increments (5.30.5 seconds) and decrements (5.60.5 seconds) were
comparable, and low frequency MCA Vmean-to-MAP phase lead was 565 and 595° (left and right hemisphere). In
MCAS, these latencies were 4.60.7 and 5.60.5 seconds in the nonischemic hemisphere and not detectable in the
ischemic hemisphere. In the unaffected hemisphere, phase lead was 616° versus 266° on the ischemic side
(P0.05). In LS, no latency and smaller phase lead bilaterally (326 and 335°) conformed to globally impaired dCA.
Conclusions—In large MCAS infarcts, dynamic cerebral autoregulation was impaired in the affected hemisphere. In LS,
dynamic cerebral autoregulation was impaired bilaterally, a finding consistent with the hypothesis of bilateral small
vessel disease in patients with lacunar infarcts. (Stroke. 2005;36:2595-2600.)
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Cerebral blood flow (CBF) is maintained by both fast- andslow-acting regulatory mechanisms spanning the pre-
vailing demands of CBF in everyday life. Static cerebral
autoregulation (CA) reflects the overall efficiency, whereas
dynamic CA (dCA) refers to the ability to restore CBF in the
face of a sudden change in perfusion pressure, that is, the
delay of CA. Acute ischemic stroke is often associated with a
temporarily elevated blood pressure (BP) returning to pre-
stroke values within days.1 Adequate BP management is of
importance, considering CA impairment in penumbral tissue.
Thus, in this setting, CBF is likely to depend on cerebral
perfusion pressure or BP. With global CBF detected by
cerebral 85Kr and 133Xe clearance, static CA in patients with
acute ischemic stroke was demonstrated to be impaired.2–4
In patients with large unilateral middle cerebral artery terri-
tory stroke (MCAS), a transient BP rise resulted in increased
MCA velocity (V) on the affected side only, suggesting
1-sided impaired static CA.5 In minor MCAS, dCA was
found not to be relevantly disturbed.6 In contrast, bilateral
dCA impairment was reported but without accounting for the
type of stroke.7–9 This study determined bilateral dCA in 2
distinct subtypes of acute ischemic stroke, that is, large MCA
territory stroke and in lacunar stroke of the basal ganglia (LS)
and in reference subjects (RS).
Methods
Subjects
Ten patients with a first occurrence of MCAS and 10 patients with
a first occurrence of LS were included in this study. Ischemic stroke
was defined as a sudden onset of a nonconvulsive and focal
neurological deficit persisting for 24 hours without signs of a
cerebral hemorrhage on computed tomography (CT) scan. Patients
were excluded from the study in case of a diminished consciousness
(Glasgow Coma Scale 10), an inadequate acoustic window, ab-
sence or insufficient quality of one of the MCA V signals, atrial
fibrillation, or significant carotid stenosis (70%). After admission
to the stroke unit, stroke severity was quantified (National Institutes
of Health Stroke Scale; maximal 42-point score) and antihyperten-
sive medication withdrawn (Table 1).
An ischemic MCAS was diagnosed by neurological examination
and CT scan. Six of 10 CT scans showed early signs of MCA
infarction, and none revealed leukoaraiosis or hemorrhage. We
diagnosed LS when a LS (pure motor stroke [in 4 patients], pure
sensory stroke [in 1 patient], sensorimotor stroke [in 1 patient],
ataxic hemiparesis [in 4 patients], or dysarthria [none]) was present.
A CT served to exclude a hemorrhagic cause. A unilateral lacunar
lesion was present in 6 of 10 CT scans made within 3 hours after
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hospital admission. Four patients had CT evidence of leukoaraiosis,
suggestive of subcortical arteriosclerotic encephalopathy. In 4 pa-
tients, no lacunar lesion was observed on the CT scan; on MRI
scanning made 3 days after admission, a lacunar lesion infarct was
present in 2 of them.
The RS had no history of cardiovascular disease and did not use
any medication. Subjects, or a direct relative, received verbal and
written explanation of the objectives and techniques of measure-
ments and risks associated with the study. Written informed consent
was provided in accordance with the Helsinki Declaration. The study
protocol was approved by the medical ethics committee of the
Academic Medical Center, University of Amsterdam, the Nether-
lands (MEC 00/061).
Protocol and Measurements
Measurements were performed at the stroke unit between 8:00 and
11:00 PM within 72 hours after onset of stroke with the patients in
supine position, in a quiet and dimly lit room to minimize arousal.
RS were studied at the same time of the evening 2 hours after a
light meal without caffeine-containing beverages. Recordings were
obtained for 15 minutes. Brachial BP was measured before the
measurements. Finger BP was measured (Portapres M2; Netherlands
Organization for Applied Scientific Research, Biomedical Instru-
mentation, TNO-BMI) with the cuff applied to the midphalanx of the
middle finger of the nonparalytic hand at heart level. To detect
changes in BP correctly, a built-in expert system (Physiocal) tracked
the unloaded diameter of the finger artery to establish and to adjust
the arterial unloaded volume.10 The transcranial Doppler-derived
blood V was measured in the proximal segments of the left and right
MCA (DWL Multidop X4). Insonation with a 2.5-MHz probe
located the MCA on the nonaffected side. Then, the patency of the
insonated vessel was evaluated more proximally. Once the internal
carotid artery bifurcation was identified, the velocity signal was
optimized with forward and reversed V set at equal intensity. We
checked the patency of the carotid arteries by Doppler imaging with
a 4.5- MHz to 5.5-MHz transducer (Hewlett Packard SONOS 2000).
Next, we located the MCA on the affected side, and waveform and
systolic flow acceleration were compared with those on the nonaf-
fected side. In case of a blunted waveform, patients were excluded
from the study. The probe was secured with a headband (Mark 600,
Spencer Technologies). End-tidal CO tension (Petco2) was monitored
by a sampling infrared capnograph (Datex Normocap 200).
Data Analysis
Finger BP, MCA V spectrum envelope, and PetCO2 were A/D
100-Hz converted and stored. Mean arterial pressure (MAP) and
MCA Vmean were the integral over 1 beat, and heart rate was taken
from the pressure interval. MAP and MCA Vmean data were interpo-
lated and resampled for time-domain dCA analysis. We selected
manually upward and downward BP transients lasting 10 seconds
at stable PetCO2. All of the 10-second episodes per 15 minutes of
tracing were isolated, and averaged curves of all of the 10-second
upward and downward BP transients were plotted. dCA is consid-
ered adequate with MCA Vmean remaining stable during a change in
MAP, apart from 5-second delay, and impaired when MCA Vmean
follows MAP passively.11 Frequency domain analysis of dCA was
performed as reported.11 In short, for examination of dCA in the
frequency domain, a 2-minute tracing of beat-to-beat data of MAP
TABLE 2. BP and MCA Blood Velocity
Variable Type
Brachial
BP, mm Hg
Finger
BP, mm Hg
MCA Vmean, cm/s1
Nonischemic Ischemic
Reference Systolic 1277 1156 926 926
Mean 954 783 613 613
Diastolic 793 592 392 402
MCAS Systolic 1439 1257 869 9010
Mean 1035 795 516 566
Diastolic 833 595 303*# 394
LS Systolic 15610* 1458* 865 846
Mean 1118 895 534 524
Diastolic 888 615 323* 313*
*P0.05 vs reference; #P0.05 vs ischemic side.
TABLE 1. Subject Characteristics
Characteristic
References,
n10
MCAS,
n10
LS,
n10
Male:Female 5:5 5:5 8:2
Age, y 572 595 633
Weight, kg 724 837 813
Length, cm 1733 1724 1762
Infarct side, L:R 6:4 4:6
NIHSS 172* 91
History of:
Hypertension 6 7
Diabetes mellitus 3 4
Hyperlipidemia 2 7
Admission:
Heart rate, min1 869 785
Systolic BP, mm Hg 1669 17816
Mean BP, mm Hg 1164 12111
Diastolic BP, mm Hg 863 939
Glucose, mmol/L1 5.301.20 6.600.49
Cholesterol–total, mmol/L1 5.180.38 6.520.40
Cholesterol–HDL, mmol/L1 1.010.10 1.230.12
Cholesterol–LDL, mmol/L1 3.080.27 3.410.37
Triglycerides, mmol/L1 2.090.36 2.280.39
ß blocker 2 5
ACE-inhibitor 2 1
ATIIRA 0 2
Diuretic 2 1
Cholesterol-lowering drug 1 4
Glucose-lowering drug 3 4
L:R indicates left vs right sided infarct; NIHSS, National Institutes of Health
Stroke Scale; ACE, angiotensin-converting enzyme; ATIIRA, angiotensin II
receptor antagonist. *P0.05 vs lacunar stroke.
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and MCA Vmean was spline interpolated and resampled at 4 Hz. With
discrete Fourier transform, the MAP and MCA Vmean variability was
expressed as the integrated areas in the very low frequency (LF; 0.02
to 0.07 Hz), low frequency (LF; 0.07 to 0.15 Hz), and the high
frequency (HF; 0.15 to 0.3 Hz) ranges. Blood pressure fluctuations in
the HF range are induced mainly by respiration, whereas those in the
LF range are independent of such influence and reflect primary
baroreflex activity. Furthermore, the very LF range of both flow and
Figure 1. MCA velocity during a change
in blood pressure in RS and in patients
with large MCA territory and lacunar
stroke; grey circles (all panels): percent-
age change in blood pressure ( BP);
top: percentage changes in left () and
right (●) mean MCA blood velocity (
MCA Vmean); middle and bottom: ische-
mic () and nonischemic (●) hemi-
sphere. Data are meanSEM.
TABLE 3. Variability in BP and MCA Blood Velocity
Variable
MAP
Variability, mm Hg/Hz2
MCA Vmean Variability
((cm/s1)/Hz2) Coherence
Nonischemic Ischemic Nonischemic Ischemic
Reference, n10
VLF 8.52.4 6.01.3 6.11.4 0.550.04 0.550.04
LF 4.00.8 2.10.4 2.20.5 0.710.04 0.720.03
HF 0.80.2 1.20.3 1.30.3 0.550.04 0.540.04
MCAS, n10
VLF 13.83.9 5.52.0 6.51.6 0.540.07 0.630.06
LF 5.01.7 1.70.3 2.30.5 0.560.08 0.610.04
HF 3.50.9 2.90.8 2.10.4 0.550.06 0.540.06
LS, n10
VLF 31.113.3* 6.92.7 9.33.9 0.620.07 0.650.07
LF 4.51.1 1.20.2 1.60.4 0.780.02 0.720.05
HF 2.00.5 1.10.3 1.20.5 0.640.03 0.590.04
MAP indicates mean arterial pressure; VLF, very low frequency. *P0.05 vs reference.
Immink et al CA in Acute Stroke 2597
pressure variability appears to reflect multiple physiological mech-
anisms, which confound interpretation. Thus, the LF range was used
to identify dCA. From the MAP–MCA Vmean cross-spectrum, transfer
function gain ([cm/s1]/mm Hg1) and MCA Vmean-to-MAP phase
lead (degrees) were calculated. The transfer function gain for MAP
and MCA Vmean (in percentage change in cm/s1 percentage change
in mm Hg) was normalized to account for intersubject variability.11
The cutoff value for preserved CA depends on the frequency range
used. We consider a phase lead 50° for the LF range to represent
preserved CA.11 With dCA impaired, as in patients with carotid
artery obstruction12 or malignant hypertension,11 phase lead de-
creases to as low as 30°.
Statistical Analysis
Data were meanSEM or median and range. Changes in systemic
and cerebral hemodynamics were examined by Kruskal-Wallis
nonparametric ANOVA. Significant changes were located with the
Wilcoxon signed-rank test. Differences in dCA between the ischemic
versus the nonischemic hemisphere and patients versus RS were
examined by nonparametric tests. P0.05 was considered to indicate
statistical significance.
Results
Subjects
Age, weight, and patient height did not differ between groups.
On admission, the National Institutes of Health Stroke Scale
was higher in MCAS, and BP was comparable (Table 1). At
the time of the study, BP was lower in both groups (Table 2).
In MCAS but not in LS, MCA V tended to be higher in the
ischemic hemisphere (P0.08).
Time Domain
In the 15-minute tracings, 2 to 10 episodes of spontaneous
MAP increases and 2 to 9 decreases of comparable magnitude
occurred in RS (183% and121%), MCAS (172% and
164%), and LS (204% and 162%). In RS, CA
latency was 5.30.5 seconds for MAP increments and
5.60.5 seconds for decrements (Figure 1). In MCAS, these
latencies were 4.60.7 and 5.60.5 seconds in the nonische-
mic hemisphere and not detectable in the ischemic hemi-
sphere. In LS, MCA Vmean passively followed MAP in both
hemispheres.
Frequency Domain
In RS, LF MCA Vmean-to-MAP phase lead was 565° (left
hemisphere) and 595° (right hemisphere). In MCAS, phase
lead was lower at the ischemic (266°; range, 10 to 50°;
P0.05) versus nonischemic side (616°; range, 17 to 73°)
with phase lead50° in 6 patients and with 50° phase lead in
1 patient (Table 3). In LS, LF phase lead was reduced
bilaterally (nonischemic: 326°; range, 5 to 49° versus
ischemic hemisphere: 335°; range, 6 to 54°; P0.05), and
gain did not differ between the hemispheres (Figure 2).
Discussion
This study determined dynamic cerebral autoregulatory ca-
pacity in the time and frequency domain in 2 main subtypes
of acute ischemic stroke: large MCAS and lacunar stroke.
The main finding is that in acute MCAS, dCA is affected at
the ischemic side only, whereas in acute LS, dCA is impaired
bilaterally.
CA characterizes cerebral artery ability to modulate arterial
wall smooth muscle tone, maintaining CBF. The latency in
dCA as derived from spontaneous MAP decreases provides
confirmatory information regarding impaired CA, as well as
Figure 2. MAP to MCA Vmean cross-
spectral phase difference and transfer
function gain. Left: left hemisphere ()
and right hemisphere (●); middle and
right: ischemic () and nonischemic
hemisphere (●). Data are meanSEM;
#P0.05 versus reference; *P0.05 ver-
sus nonischemic side.
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produced data akin to rapid thigh-cuff deflation as a stimulus
for dCA.13
CA in stroke is controversial. In large MCAS, a transient
rise in BP by phenylephrine raises MCA Vmean on the affected
side only, indicating unilaterally impaired static CA.5 Sev-
eral2–4 but not all7 reports suggest global static CA impair-
ment. So far, global bihemispheric dCA impairment in acute
and subacute stroke with preserved static CA has been
reported without obvious differences between stroke sub-
types.7–9 In subsequent studies, dCA appeared impaired
bilaterally8 and remained so for at least 1 to 2 weeks,9
although this was not confirmed in minor MCAS.6 MCA
territory infarcts are likely to result from embolism or large
cerebral artery artherothrombosis with a considerable penum-
bral tissue volume. The present study extends the observa-
tions of unilaterally impaired static CA in MCAS5 to unilat-
eral impairment of dCA.
In contrast to what was found in large MCAS, dCA was
affected bilaterally in 1-sided LS. Intracranial small artery
occlusion is the probable cause in the majority of LS.14 The
penumbral volume in LS is usually small, and we consider
dCA impairment in LS by the ischemic event itself unlikely.15
In syndromes with more extensive atherosclerosis of both
extracranial and intracranial vessels, such as longstanding
diabetes, CA is impaired.16 Cerebral small-vessel disease can
produce isolated lacunar infarcts or diffuse white matter
changes appearing as leukoaraiosis on a CT or MRI,17,18
which may explain why dCA in LS was affected on the
nonischemic side as well. We examined CA capacity in acute
stroke patients. In a follow-up study of patients experiencing
minor MCAS, CA was still abnormal on the affected side but
preserved on the normal side 2 months after stroke onset.19
We did not assess CA capacity before LS, but we speculate
that a globally impaired dCA was already present.
In this study, CT scanning was the primary imaging technique
used on admission. More ischemic strokes show up on diffusion-
weighted imaging than on CT or conventional MRI in the first
few hours. However, MRI can be difficult to use routinely in
acute stroke and may not identify hyperacute intracerebral
hemorrhage correctly, whereas CT scans are superior for differ-
entiating ischemic from hemorrhagic stroke.18,20 In addition,
lacunar syndromes are highly predictive for small deep infarcts
on magnetic resonance. For that reason, brain MRI has even
been considered redundant in the setting of a lacunar syndrome
if supported by a CT that excludes nonischemic causes of
stroke.21 An inherent difficulty of both CT and MRI is the ability
to differentiate between acute and chronic lesions. In spite of the
problem of relating lacunar syndromes to certain locations of
lacunae,22 our finding that CA capacity was impaired also in
the contralateral (“healthy”) hemisphere in LS remains
unchallenged.
Critical for the interpretation of the data are to what extent
MCA Vmean reflects volume flow. The MCA Vmean is assumed
to represent flow velocity in the center of the vessel, and,
when flow is laminar, MCA Vmean follows 133Xe clearance-
determined CBF.23 Thus, the constancy of vessel diameter
links changes in MCA V to those in CBF. When nonlaminar
blood flow in the affected cerebral arteries is considered, MCA
Vmean may change out of proportion to flow, and, therefore, the
analysis was restricted to normally shaped Doppler signals.24
CA was assessed after discontinuation of antihyper-
tensive treatment, but a remaining biological effect cannot
be excluded. However, also with  blockade, angiotensin-
converting enzyme inhibition or angiotensin-receptor antag-
onist treatment intergrety of CA has been confirmed. We did
not create different steady-state BP levels, and quantification
of static CA as established by Schwarz et al5 was not carried
out. Impairment of static CA by pharmacological manipula-
tion also affects dCA,25 and we, therefore, consider that the
impaired dCA found in this study suggests impairment of
static CA as well.11
Conclusions
In large MCAS infarcts, dCA was impaired in the affected
hemisphere only. In LS, dCA was impaired bilaterally. The
latter finding is consistent with the hypothesis of bilateral
small vessel disease in patients with lacunar infarcts.
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